Previous 10 | Next 10 |
PerkinElmer, Inc. (PKI) Q3 2021 Earnings Conference Call November 02, 2021 5:00 PM ET Company Participants Stephen Willoughby - Vice President of Investor Relations Prahlad Singh - President and Chief Executive Officer James Mock - Senior Vice President and Chief Financial Officer Peter Wrigh...
PerkinElmer (NYSE:PKI): Q3 Non-GAAP EPS of $2.31 beats by $0.56; GAAP EPS of $1.11 misses by $0.16. Revenue of $1.17B (+21.4% Y/Y) beats by $120M. Shares +1.71%. Press Release For Q4, the company forecasts adjusted revenue of approximately $1.2B vs. consensus of $1.05B and adjusted earnings p...
Revenue of $1.17 billion; 21% reported growth; 12% organic growth GAAP EPS from continuing operations of $1.11; Adjusted EPS of $2.31 Initiates Fourth Quarter Guidance and Raises Full Year Revenue and Earnings Guidance PerkinElmer, Inc . (NYSE: PKI), ...
Report highlights stewardship and sustainability progress and solidifies new ESG commitments PerkinElmer, Inc. (NYSE: PKI), a global leader innovating for a healthier world, today released its 2021 Corporate Social Responsibility (CSR) Report, which summarizes the latest...
Enzo Biochem (NYSE:ENZ) has added ~6.1% in the pre-market after the company announced Hamid Erfanian as its new CEO effective Nov. 08. Mr. Erfanian will replace former CEO Elazar Rabbani, who will step down according to a previously announced succession plan. Dr. Rabbani will b...
Flagship product from Honeycomb Biotechnologies advances single-cell profiling by enabling scientists to capture, store and study fragile cell types PerkinElmer, Inc. (NYSE: PKI) and Honeycomb Biotechnologies, Inc. , announced today the commercial launch of the f...
A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IBB. A list of cheap stocks. For further details see: IBB: Healthcare Dashboard For October
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will release its third quarter 2021 financial results after market close on Tuesday, November 2, 2021. The Company will host a conference call the same day ...
RT-PCR test detects and differentiates SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the PKamp™...
Assay enabling the measurement of IgG antibodies could yield future discoveries and insights on immune responses to SARS-CoV-2 EUROIMMUN , a PerkinElmer, Inc. company (NYSE: PKI), announced today that the U.S. Food and Drug Administration has provided Emergency Use A...
News, Short Squeeze, Breakout and More Instantly...
Revenue of $675 million; (30)% reported growth; (27)% organic growth; 6% non-COVID organic growth GAAP EPS of $4.50; Adjusted EPS from continuing operations of $1.01 Updates full year 2023 guidance Authorizes new $600 million share repurchase program To begin tradi...
Transformation aimed at revolutionizing next generation scientific breakthroughs that solve the world’s greatest health challenges Trusted partner to pharma, government and diagnostics customers with complete, end-to-end solutions To begin trading as RVTY under new name on ...
2023-05-07 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...